Preliminary evidence that long-term estrogen use reduces white matter loss in aging
- PMID: 17030475
- PMCID: PMC2151930
- DOI: 10.1016/j.neurobiolaging.2006.08.007
Preliminary evidence that long-term estrogen use reduces white matter loss in aging
Abstract
Despite numerous studies showing neurotrophic and neuroprotective effects of estrogen in animal models, the long-term effects of estrogen use on brain morphology in older women are not known. Thus, we compared ventricular, cerebrospinal fluid, white matter, and grey matter volumes estimated from magnetic resonance images of postmenopausal women with more than 20 years exposure to unopposed estrogen, women who were not on estrogen, and young healthy women. Estrogen users had significantly smaller ventricles and greater white matter volumes than non-users, but hormone exposure did not affect grey matter volumes. Young healthy women had significantly smaller ventricles, less cerebrospinal fluid and more grey matter than both groups of older women. However, they had comparable white matter volumes to older women on estrogen. These findings suggest that long-term estrogen protects against white matter loss in aging. This adds to findings from other studies suggesting estrogen is neuroprotective of the hippocampus and other regions in older women.
Figures
Similar articles
-
Brain volumes in late life: gender, hormone treatment, and estrogen receptor variants.Neurobiol Aging. 2014 Mar;35(3):645-54. doi: 10.1016/j.neurobiolaging.2013.09.026. Epub 2013 Oct 23. Neurobiol Aging. 2014. PMID: 24269019
-
White matter loss in healthy ageing: a postmortem analysis.Neurobiol Aging. 2009 Aug;30(8):1288-95. doi: 10.1016/j.neurobiolaging.2007.10.015. Epub 2008 Feb 20. Neurobiol Aging. 2009. PMID: 18077060
-
The myelinated fiber changes in the white matter of aged female Long-Evans rats.J Neurosci Res. 2009 May 15;87(7):1582-90. doi: 10.1002/jnr.21986. J Neurosci Res. 2009. PMID: 19125406
-
Brain aging modulates the neuroprotective effects of estrogen on selective aspects of cognition in women: a critical review.Front Neuroendocrinol. 2008 Jan;29(1):88-113. doi: 10.1016/j.yfrne.2007.08.002. Epub 2007 Oct 1. Front Neuroendocrinol. 2008. PMID: 17980408 Review.
-
Neuroimaging of aging and estrogen effects on central nervous system physiology.Fertil Steril. 2001 Oct;76(4):651-9. doi: 10.1016/s0015-0282(01)01985-9. Fertil Steril. 2001. PMID: 11591393 Review.
Cited by
-
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Biol Sex Differ. 2013 Mar 28;4(1):6. doi: 10.1186/2042-6410-4-6. Biol Sex Differ. 2013. PMID: 23537114 Free PMC article.
-
Women's brain aging: Effects of sex-hormone exposure, pregnancies, and genetic risk for Alzheimer's disease.Hum Brain Mapp. 2020 Dec 15;41(18):5141-5150. doi: 10.1002/hbm.25180. Epub 2020 Aug 28. Hum Brain Mapp. 2020. PMID: 32856754 Free PMC article.
-
Adverse impact of female reproductive signaling on age-dependent neurodegeneration after mild head trauma in Drosophila.Elife. 2024 Aug 30;13:RP97908. doi: 10.7554/eLife.97908. Elife. 2024. PMID: 39213032 Free PMC article.
-
Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause.Am J Primatol. 2009 Sep;71(9):794-801. doi: 10.1002/ajp.20705. Am J Primatol. 2009. PMID: 19475542 Free PMC article. Review.
-
Considering the role of estradiol in the psychoneuroimmunology of perimenopausal depression.Brain Behav Immun Health. 2024 Jul 21;40:100830. doi: 10.1016/j.bbih.2024.100830. eCollection 2024 Oct. Brain Behav Immun Health. 2024. PMID: 39161877 Free PMC article.
References
-
- Allen JS, Bruss J, Brown CK, Damasio H. Normal neuroanatomical variation due to age: the major lobes and a parcellation of the temporal region. Neurobiol Aging. 2005;26:1245–1260. - PubMed
-
- Bebo BF, Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol. 2001;166:2080–2089. - PubMed
-
- Cook IA, Morgan ML, Dunkin JJ, David S, Witte E, Lufkin R, Abrams M, Rosenberg S, Leuchter AF. Estrogen replacement therapy is associated with less progression of subclinical structural brain disease in normal elderly women: a pilot study. Int J Geriatr Psychiatry. 2002;17:610–618. - PubMed
-
- Eberling JL, Wu C, Haan MN, Mungas D, Buonocore M, Jagust WJ. Preliminary evidence that estrogen protects against age-related hippocampal atrophy. Neurobiol Aging. 2003;24:725–732. - PubMed
-
- Eberling JL, Wu C, Tong-Turnbeaugh R, Jagust WJ. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage. 2004;21:364–371. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG012611-09/AG/NIA NIH HHS/United States
- R01 AG018843-03/AG/NIA NIH HHS/United States
- M01 RR000334/RR/NCRR NIH HHS/United States
- R01 AG018843/AG/NIA NIH HHS/United States
- R01AG12611/AG/NIA NIH HHS/United States
- R01 AG012611-10/AG/NIA NIH HHS/United States
- 5M01 RR000334/RR/NCRR NIH HHS/United States
- M01 RR000334-310433/RR/NCRR NIH HHS/United States
- R01AG18843/AG/NIA NIH HHS/United States
- R01 AG012611-11/AG/NIA NIH HHS/United States
- R01 AG018843-04/AG/NIA NIH HHS/United States
- R01 AG012611/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
